Does motherwort help with anxiety, high blood pressure and heart palpitations?

Motherwort contains a distinctive chemical profile that sets it apart from most Western herbs:

Leonurine is an alkaloid found almost exclusively in the Leonurus genus. It acts on multiple targets simultaneously: it binds directly to GABA-A receptors (explaining the calming, anxiolytic effect), relaxes vascular smooth muscle (contributing to mild blood pressure lowering), and stimulates uterine smooth muscle contractions^3,5. In cardiac tissue, it reduces automaticity — the tendency of heart cells to fire spontaneously — which helps normalize an irregular or racing pulse¹.

Stachydrine is a betaine alkaloid that has attracted interest for its effects on uterine muscle tone and its mild anti-platelet activity⁵. Some research suggests stachydrine may reduce luteinizing hormone levels, potentially explaining motherwort's historical use for menstrual regulation¹.

Flavonoids including rutin, quercetin, hyperoside, and apigenin contribute antioxidant and anti-inflammatory activity. In heart tissue specifically, these flavonoids modify mitochondrial oxidative phosphorylation in a way that reduces reactive oxygen species (ROS) without impairing ATP production — a cardioprotective effect distinct from simply scavenging free radicals².

Iridoids (ajugol, leonuride) and phenolic acids round out the profile with additional anti-inflammatory contributions¹.

Primary Uses

Heart palpitations and mild hypertension. Motherwort is one of the most studied European botanicals for functional heart complaints — racing pulse, irregular beats, and the anxious chest tightening that accompanies stress. The combination of GABA modulation (calming the nervous system) and direct cardiac effects (reducing automaticity) makes it especially suited to cases where anxiety and cardiac symptoms feed on each other⁴.

Anxiety and sleep disturbances. Because leonurine binds to GABA-A receptors — the same receptor family targeted by benzodiazepines and valerian — motherwort has a mild but pharmacologically real sedative action³. It is gentler than pharmaceutical anxiolytics and does not appear to cause dependence, making it practical for daily or situational use.

Menstrual support. Traditional European and Chinese herbal medicine both use motherwort for delayed, painful, or irregular menstruation. The uterotonic effects of leonurine and stachydrine provide a mechanistic basis for this use, though formal clinical trials in this area are limited⁵. For women with primary dysmenorrhea or irregular cycles, it is often combined with vitex or cramp bark.

Postpartum recovery. The European Medicines Agency assessment notes motherwort's traditional use for postpartum conditions, including retained uterine tone and the mood disruptions of the early postnatal period⁵.

Practical Dosage and Forms

The most studied dose in humans is 1200 mg/day of a standardized extract, divided into two or three doses⁴. Traditional European herbalism used infusions made from the dried aerial parts (leaves and flowers), typically 2–4 g dried herb in hot water, taken two to three times daily. Tinctures are widely available and convenient; look for a 1:5 extract in 25–40% ethanol.

Effects on anxiety and palpitations are often noticeable within the first week. Blood pressure effects, where present, typically develop over three to four weeks of consistent use.

Important caution: Leonurine and stachydrine stimulate uterine contractions. Motherwort is contraindicated during pregnancy. It should be used with caution alongside cardiac medications (antiarrhythmics, beta-blockers, antihypertensives) due to potential additive effects — discuss with a healthcare provider before combining.

See our hawthorn berry page for another well-researched botanical for heart health, and our passionflower page for a complementary GABA-active herb for anxiety and sleep.

Phytochemical and pharmacological overview. Wojtyniak et al. (2013) published a comprehensive review in Phytotherapy Research covering the full phytochemistry and documented pharmacology of Leonurus cardiaca¹. The review identifies over 100 secondary metabolites, with leonurine, stachydrine, and iridoids highlighted as the primary bioactive contributors. Documented activities include antibacterial effects (particularly against Staphylococcus aureus), antioxidant activity (DPPH radical scavenging IC50 values comparable to standard antioxidants in several assays), anti-inflammatory activity (cyclooxygenase inhibition, TNF-alpha suppression in cell models), analgesic properties in rodent pain models, sedative effects, and hypotensive effects. The review notes that most mechanistic evidence is from in vitro and animal studies, with a limited but growing clinical literature¹.

Mitochondrial cardioprotection. Bernatoniene et al. (2014) examined the effects of Leonurus cardiaca extract and five isolated flavonoids on mitochondrial function in rat heart tissue². The extracts and flavonoids modified mitochondrial uncoupling (decreasing the coupling efficiency of oxidative phosphorylation), which paradoxically provides cardioprotection by reducing the electron leak that generates ROS during ischemia-reperfusion events. This mitochondrial uncoupling is recognized as a physiological protective mechanism in cardiac tissue. The five identified active flavonoids — rutin, quercetin, hyperoside, luteolin, and apigenin — all showed activity, with the whole extract exhibiting effects that could not be fully replicated by any single compound, suggesting synergy². This is a preclinical study in isolated tissue, so translation to clinical endpoints requires additional investigation.

GABA receptor mechanism. Rauwald et al. (2015) performed radioligand binding assays to measure how standardized Leonurus cardiaca extracts and isolated constituents compete with muscimol (a GABA-A agonist) for receptor binding³. Leonurine showed binding affinity to the GABA-A receptor site (Ki values in the micromolar range), confirming a direct pharmacological mechanism for the herb's anxiolytic and sedative effects. The study tested both L. cardiaca and the Chinese species L. japonicus, finding similar binding activity in both. This provides a molecular basis for what traditional European herbalists described simply as "calming the heart," and places motherwort's mechanism alongside better-known GABAergic herbs such as valerian and passionflower³.

Clinical trial in hypertension with anxiety. Shikov et al. (2011) conducted the most clinically significant human trial of motherwort to date, enrolling 50 patients with arterial hypertension accompanied by anxiety and sleep disturbances⁴. Subjects received a standardized Leonurus cardiaca oil extract at 1200 mg/day for 28 days. Outcomes were assessed using validated scales for anxiety (HADS-A), sleep quality, and blood pressure measurement. 32% of patients showed significant improvement across all three parameters; an additional 48% showed moderate improvement — a combined response rate of 80%⁴. Mean systolic blood pressure fell by approximately 12 mmHg and diastolic by 7 mmHg in responders. Anxiety and sleep scores improved in parallel. The trial lacked a placebo arm, which limits the ability to attribute effects exclusively to the herb (particularly for blood pressure, where regression to the mean is substantial). However, the magnitude and breadth of the response — especially the sleep and anxiety improvements — are difficult to explain entirely by placebo. The authors noted no significant adverse events⁴.

EMA bioactive compound update. Fierascu et al. (2019) reviewed the literature published after the European Medicines Agency's 2010 assessment report on motherwort, synthesizing research from 2010 to 2018⁵. The update confirmed the traditional use categories recognized by the EMA: relief of symptoms associated with nervous cardiac complaints (palpitations, tachycardia, anxiety) and relief of mild menstrual disorders. New research highlighted stachydrine's effects on female reproductive physiology, including suppression of luteinizing hormone secretion in rodent models, providing mechanistic support for menstrual-regulating effects. The update also noted emerging evidence for antioxidant neuroprotection and possible anti-proliferative activity in some cancer cell lines in vitro — areas that require human clinical data before clinical conclusions can be drawn⁵.

Evidence strength assessment. The evidence base for motherwort falls into two categories. For the traditional indications of heart palpitations and anxiety accompanying mild hypertension, the mechanistic evidence is solid (GABA binding, cardiac ion channel effects, antioxidant activity) and supported by one positive open-label clinical study and a long, well-documented history of use in European phytomedicine — classified by the EMA as "traditional use with plausible efficacy." For menstrual applications, the evidence is primarily mechanistic and traditional, without RCTs. Formal double-blind placebo-controlled trials are notably absent from the literature; this is the primary gap in the evidence base. Motherwort is best used as a supportive botanical for functional cardiac and anxiety complaints, with realistic expectations that it provides gentle, multi-target support rather than dramatic pharmacological intervention.